SOURCE DiagnoCure inc.
Positives seen for bulls and bears as traders shrug off risk.
TheStreet's biotech columnist offers his own report card on biotech stocks.
These under-$10 stocks are ready to move higher from current levels. Here's how to trade them from here.
A much-hyped press conference reveals nothing new about Brainstorm's stem-cell therapy for ALS.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.